ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Alpine Immune and AbbVie sign $865m immunology deal pharmaceutical-technology
June 22, 2020Clinical-stage immunotherapy firm Alpine Immune Sciences and biopharmaceutical company AbbVie have signed an option and license agreement potentially worth $805m, for ALPN-101 drug.
Pharma Sources Insight January 2025
